A 28-year-old woman from North India presents with fever for 5 days, severe headache, petechial rash on the trunk and extremities, and a history of tick bite 10 days ago. Routine blood culture is negative. Which is the most specific investigation for confirming Rocky Mountain spotted fever (RMSF)?

Explanation

## Diagnosis of Rocky Mountain Spotted Fever (RMSF): Investigation of Choice ### Clinical Context The patient presents with classic RMSF: fever, severe headache, petechial rash (centripetal distribution), and recent tick exposure. Early diagnosis is critical because untreated RMSF has high mortality (20–30%). Serological tests may be negative in the first week, necessitating alternative confirmatory methods. ### Investigation Comparison for RMSF | Investigation | Sensitivity | Specificity | Timing | Availability | Clinical Use | |---|---|---|---|---|---| | **IHC (skin biopsy)** | 70–90% | >95% | Acute phase (Day 3–7) | Limited | Gold standard for acute diagnosis | | **Serum IgM (ELISA)** | 90–95% | >95% | Day 7–10 onwards | Widely available | Gold standard serology (delayed) | | **Weil-Felix test** | 50–80% | Low | Day 5–7 | Widely available | Screening; non-specific | | **Culture (shell vial)** | 60–80% | 100% | Requires 5–7 days | Specialized labs only | Research; not practical clinically | ### Key Point: **Immunohistochemistry (IHC) of skin biopsy from a petechial lesion is the most specific acute-phase investigation** because it: 1. Detects *Rickettsia rickettsii* antigen directly in endothelial cells of dermal vessels 2. Provides diagnosis during the acute febrile phase (Day 3–7) when serological tests may still be negative 3. Has >95% specificity with no cross-reactivity 4. Allows immediate therapeutic decision-making without waiting for seroconversion 5. Is the recommended investigation by CDC for early RMSF confirmation ### High-Yield: **Mnemonic for RMSF Diagnosis: IHC-IgM-WF-Culture** - **IHC**: Earliest, most specific (acute phase, endothelial antigen) - **IgM**: Gold standard serology (Day 7–10, paired sera) - **WF**: Screening only; low specificity - **Culture**: Gold standard but impractical (slow, requires BSL-3) ### Clinical Pearl: In endemic areas (North America, parts of India), skin biopsy with IHC is recommended for patients with suspected RMSF presenting within the first week of illness. The biopsy should be taken from a petechial or rash lesion (NOT the eschar, which is rare in RMSF). Early IHC confirmation allows immediate doxycycline therapy, which reduces mortality from 20% to <5% when started within the first 5 days. ### Pathology of IHC Positivity *Rickettsia rickettsii* infects endothelial cells of small vessels, causing vasculitis. IHC detects rickettsial antigen in the vessel wall using specific antibodies against the organism. This is visible as brown precipitate (DAB substrate) in the endothelium. ### Why Serology is Delayed 1. **Day 0–6**: Seronegative ("serologically silent" period) 2. **Day 7–10**: IgM becomes positive 3. **Day 10–14**: IgG becomes positive 4. **Paired sera**: Acute and convalescent (2–4 week interval) required for diagnosis This delay makes serology unsuitable for early treatment decisions in RMSF, where mortality increases with delayed therapy. [cite:Harrison 21e Ch 180; CDC RMSF Guidelines]